ACHC Acadia Healthcare Company, Inc.
Services-Specialty Outpatient Facilities, NEC · Nasdaq · SEC CIK 1520697 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY4.5%
TTM net income YoY-1,150.7%
TTM EPS YoY-1,154.2%
Revenue 3-yr CAGR6.0%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin-33.1%
FCF margin-0.7%
EBITDA margin—
Returns
ROE-43.9%
ROA-18.9%
ROIC (approx.)—
Asset turnover0.57x
Leverage & solvency
Liabilities / assets59.5%
Debt / equity1.16x
Current ratio1.60x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.21x
Accruals ratio-22.8%
Payout ratio—
Capex / revenue7.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $3.31B | $3.15B | $2.93B | $2.61B | $2.31B |
| SG&A expense | $177.60M | $156.80M | $153.30M | $124.30M | $108.20M |
| Pretax income | -$1.07B | $341.88M | -$25.36M | $374.14M | $275.76M |
| Income tax | $25.98M | $77.39M | -$9.70M | $94.11M | $67.56M |
| Net income | -$1.10B | $255.61M | -$21.67M | $273.14M | $190.63M |
| EPS (basic) | -12.16 | 2.79 | -0.24 | 3.05 | 2.15 |
| EPS (diluted) | -12.16 | 2.78 | -0.24 | 2.98 | 2.10 |
| Weighted avg. shares (diluted) | 90.70M | 92.06M | 90.95M | 91.56M | 90.79M |
| Banking | |||||
| Net interest income | -$138.86M | -$116.37M | -$82.12M | -$69.76M | -$76.99M |
| Balance sheet | |||||
| Cash & equivalents | $133.24M | $76.31M | $100.07M | $97.65M | $133.81M |
| Receivables | $440.60M | $365.34M | $361.45M | $322.44M | $281.33M |
| Inventory | $5.69M | $5.65M | $5.30M | $5.09M | $4.79M |
| Current assets | $814.14M | $577.49M | $596.00M | $506.12M | $495.03M |
| PP&E, net | $3.11B | $2.85B | $2.27B | $1.95B | $1.77B |
| Goodwill | $1.30B | $2.26B | $2.23B | $2.22B | $2.20B |
| Intangibles | $96.67M | $70.00M | $73.28M | $76.04M | $70.14M |
| Total assets | $5.53B | $5.96B | $5.36B | $4.99B | $4.77B |
| Current liabilities | $525.19M | $577.92M | $885.78M | $388.33M | $404.86M |
| Short-term debt | $28.44M | $76.82M | $29.22M | $21.25M | $18.59M |
| Long-term debt | $2.47B | $1.88B | $1.34B | $1.36B | $1.48B |
| Total debt | $2.50B | $1.96B | $1.37B | $1.39B | $1.50B |
| Total liabilities | $3.39B | $2.77B | $2.47B | $2.09B | $2.19B |
| Shareholders' equity | $1.95B | $3.07B | $2.78B | $2.81B | $2.52B |
| Net debt | $2.37B | $1.88B | $1.27B | $1.29B | $1.36B |
| Shares outstanding | 90.45M | 91.78M | 91.26M | 89.91M | 89.03M |
| Cash flow statement | |||||
| Operating cash flow | $131.90M | $129.69M | $462.34M | $380.57M | $374.48M |
| Capital expenditure | $571.81M | $690.38M | $424.13M | $296.15M | $244.81M |
| Free cash flow | -$439.91M | -$560.69M | $38.21M | $84.42M | $129.67M |
| Investing cash flow | -$556.21M | -$736.48M | -$397.22M | -$305.83M | $1.01B |
| Financing cash flow | $481.25M | $583.02M | -$62.70M | -$110.90M | -$1.64B |
| Depreciation & amortization | $189.25M | $149.59M | $132.35M | $117.77M | $106.72M |
| Stock-based compensation | $31.71M | $37.11M | $32.29M | $29.64M | $37.53M |
| Share buybacks | $50.03M | — | — | — | — |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.